October 24, 2008
VioQuest Pharmaceuticals Provides Strategic Alternatives Review and Operations Update

September 10, 2008
VioQuest Pharmaceuticals Receives 510(k) Response from FDA for Xyfid™

August 26, 2008
VioQuest Pharmaceuticals Announces Issuance of New U.S. Patent for Lenocta™

August 19, 2008
VioQuest Pharmaceuticals Announces Second Quarter 2008 Financial Results and Corporate Highlights

July 30, 2008
VioQuest Pharmaceuticals’ VQD-002 Named One of 10 Most Promising Oncology Projects by Windhover